Cargando…

Clinical Efficacy of Temozolomide and Its Predictors in Aggressive Pituitary Tumors and Pituitary Carcinomas: A Systematic Review and Meta-Analysis

Background: A growing number of evidences suggest that TMZ applications can generate impressive benefits for APT and PC patients. However, the definite role of TMZ for individuals remains unclarified due to the variation between studies. And the predictive factors to alter its efficacy remain debata...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Mei, Tan, Yiheng, Chen, Wenli, Hu, Bin, Wang, Zongming, Zhu, Diming, Jiao, Haosen, Duan, Chengbin, Zhu, Yonghong, Wang, Haijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250148/ https://www.ncbi.nlm.nih.gov/pubmed/34220696 http://dx.doi.org/10.3389/fneur.2021.700007

Ejemplares similares

Prediction of the Recurrence of Non-Functioning Pituitary Adenomas Using Preoperative Supra-Intra Sellar Volume and Tumor-Carotid Distance
por: Chen, Wenli, et al.
Publicado: (2021)

Temozolomide in aggressive pituitary adenomas and carcinomas
por: Ortiz, Leon D., et al.
Publicado: (2012)

Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain
por: Lamas, Cristina, et al.
Publicado: (2023)

SUN-272 Significant Response to Temozolomide in Two Aggressively Growing Pituitary Adenomas
por: Kreitschmann-Andermahr, Ilonka, et al.
Publicado: (2020)

Early Initiation of Temozolomide Therapy May Improve Response in Aggressive Pituitary Adenomas
por: Das, Liza, et al.
Publicado: (2021)

Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas with Adjuvant Temozolomide Chemotherapy: A Review
por: Moisi, Marc, et al.
Publicado: (2016)

MON-406 Two Cases of Aggressive Corticotroph Pituitary Tumors Treated with Capecitabine and Temozolomide
por: Tateno, Tae, et al.
Publicado: (2019)

Pituitary stalk changes on magnetic resonance imaging following pituitary adenoma resection using a transsphenoidal approach
por: Zhang, Huijian, et al.
Publicado: (2023)

Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review
por: Zhu, Dimin, et al.
Publicado: (2022)

Combined treatment with artesunate and bromocriptine has synergistic anticancer effects in pituitary adenoma cell lines
por: Wang, Xin, et al.
Publicado: (2017)

Surgical treatment of aggressive pituitary adenomas and pituitary carcinomas
por: Buchfelder, Michael, et al.
Publicado: (2020)

Temozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina
por: Bruno, Oscar D., et al.
Publicado: (2015)

Temozolomide and Capecitabine Treatment for an Aggressive Somatotroph Pituitary Tumor: A Case Report and Literature Review
por: Ishida, Atsushi, et al.
Publicado: (2022)

Temozolomide therapy: Focus on patients with pituitary carcinoma
por: Curtò, Lorenzo
Publicado: (2016)

Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment
por: Burman, Pia, et al.
Publicado: (2023)

A Rapid Biochemical and Radiological Response to the Concomitant Therapy with Temozolomide and Radiotherapy in an Aggressive ACTH Pituitary Adenoma
por: Misir Krpan, Ana, et al.
Publicado: (2017)

Pituitary Adenoma with Calcifications: A Case Report
por: Khan, Yakoot, et al.
Publicado: (2019)

Endoscopic endonasal surgery for non-invasive pituitary neuroendocrinology tumors with incomplete pseudocapsule
por: Zhang, Gang, et al.
Publicado: (2023)

Correction to “Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment”
Publicado: (2023)

Pituitary Crooke Cell Adenoma: Two Cases of an Aggressive Pituitary Adenoma
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

Long-term remission in an aggressive Crooke cell adenoma of the pituitary, 18 months after discontinuation of treatment with temozolomide
por: Asimakopoulou, Athina, et al.
Publicado: (2014)

Pituitary Teratoma: A Case Series of Three Cases
por: Tena Suck, Martha L, et al.
Publicado: (2023)

A Case of Nonfunctioning Pituitary Carcinoma That Responded to Temozolomide Treatment
por: Morokuma, Haruko, et al.
Publicado: (2012)

MON-407 Tumor Control after Radiotherapy and Temozolomide in a Cushing's Disease Patient with Giant Aggressive Pituitary Tumor
por: Valente do Couto, Hugo, et al.
Publicado: (2019)

Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report
por: Mirallas, Oriol, et al.
Publicado: (2021)

Pituitary apoplexy in a pregnant woman
por: Parihar, Vijay, et al.
Publicado: (2009)

Pituitary apoplexy presented with optic neuritis
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2013)

Using 2-dimensional hand photographs to predict postoperative biochemical remission in acromegaly patients: a transfer learning approach
por: Wang, Mengqi, et al.
Publicado: (2023)

Temozolomide and Pituitary Tumors: Current Understanding, Unresolved Issues, and Future Directions
por: Syro, Luis V., et al.
Publicado: (2018)

Epidemiology of Pediatric Traumatic Brain Injury and Hypothalamic-Pituitary Disorders in Arizona
por: Ortiz, J. Bryce, et al.
Publicado: (2020)

MRI Imaging of Double Pituitary Microadenoma: A Rare Preoperative Diagnosis
por: Bhansali, Pratik J, et al.
Publicado: (2022)

Future treatment strategies of aggressive pituitary tumors
por: Lamberts, Steven W. J., et al.
Publicado: (2008)

The epidemiology of aggressive pituitary tumors (and its challenges)
por: Dekkers, Olaf M., et al.
Publicado: (2020)

Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives
por: Bioletto, Fabio, et al.
Publicado: (2022)

Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors
por: Nakano-Tateno, Tae, et al.
Publicado: (2021)

Incidence rate and risk factors of early repolarization in patients with growth hormone-secreting pituitary adenoma: a cohort study
por: Chen, Zhiyong, et al.
Publicado: (2018)

Socioeconomic Predictors of Pituitary Surgery
por: Deb, Sayantan, et al.
Publicado: (2019)

Longitudinal changes in the hypothalamic–pituitary–adrenal axis and sympathetic nervous system are related to the prognosis of stroke
por: Chen, Xu-Guang, et al.
Publicado: (2022)

Microscopic Transsphenoidal Resection of Giant Pituitary Adenomas: Analysis of the Factors Limiting the Degree of Resection in 73 Cases
por: Pei, Zhijie, et al.
Publicado: (2022)

A Meta-Analysis of Endoscopic vs. Microscopic Transsphenoidal Surgery for Non-functioning and Functioning Pituitary Adenomas: Comparisons of Efficacy and Safety
por: Guo, Shengfu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3t8t8c79flgcub7ue4hul9urjm